Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease
Author
Source
Issue
Vol. 2010, Issue 2010 (31 Dec. 2010), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2009-12-22
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Myocardial MIBG scintigraphy is established in the diagnosis and differential diagnosis of Parkinson's disease (PD).
Numerous studies address the pathophysiological impact of myocardial MIBG scintigraphy: the myocardial MIBG uptake correlates with the clinical phenotype of PD; the background of this phenomenon is unclear.
Furthermore MIBG scintigraphy enables to study the extracranial Lewy body type-degeneration.
In combination with cerebral dopamine transporter imaging, MIBG scintigraphy allows to correlate cerebral and extracranial Lewy body type-degeneration in PD.
American Psychological Association (APA)
Spiegel, Jörg. 2009. Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease. ISRN Cell Biology،Vol. 2010, no. 2010, pp.1-6.
https://search.emarefa.net/detail/BIM-461221
Modern Language Association (MLA)
Spiegel, Jörg. Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease. ISRN Cell Biology No. 2010 (2010), pp.1-6.
https://search.emarefa.net/detail/BIM-461221
American Medical Association (AMA)
Spiegel, Jörg. Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease. ISRN Cell Biology. 2009. Vol. 2010, no. 2010, pp.1-6.
https://search.emarefa.net/detail/BIM-461221
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-461221
